http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-06-27T19:02:05.302Z

http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

amiloride hcl tablets are indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in congestive heart failure or hypertension to a help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic diuretic b prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop e g digitalized patients or patients with significant cardiac arrhythmias the use of potassium conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet amiloride hcl tablets have little additive diuretic or antihypertensive effect when added to a thiazide diuretic amiloride hcl tablets should rarely be used alone it has weak compared with thiazides diuretic and antihypertensive effects used as single agents potassium sparing diuretics including amiloride hcl tablets result in an increased risk of hyperkalemia approximately 1 with amiloride amiloride hcl tablets should be used alone only when persistent hypokalemia has been documented and only with careful titration of the dose and close monitoring of serum electrolytes

Leoni Bücken

2021-06-27T19:02:05.302Z

http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_10763 DOID_10763

Leoni Bücken

2021-06-27T19:02:05.302Z

http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-06-27T19:02:05.302Z

http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB00594 drugbank:DB00594

Leoni Bücken

2021-06-27T19:02:05.302Z

http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-06-27T19:02:05.302Z

http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-06-27T19:02:05.302Z

http://purl.org/np/RAvlK_y84I... RAvlK_y84I

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://schema.org/TreatmentIndication TreatmentIndication

Leoni Bücken

2021-06-27T19:02:05.302Z